Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells

Alzheimer's disease (AD) is a progressive pathology that is linked to abrupt aggregation of amyloid β<sub>1-42</sub> (Aβ<sub>1-42</sub>) peptide in the central nervous system. Aβ<sub>1-42</sub> aggregation yields amyloid oligomers and fibrils, toxic protein aggregates that cause progressive neuronal degeneration in the frontal lobe of the brain. Although neurons remain the focus of AD for decades, a growing body of evidence suggests that the degeneration of immune cells in the brain can be the major cause of AD. However, the extent to which Aβ<sub>1-42</sub> aggregates are toxic to the major classes of immune cells in the brain remains unclear. In the current study, we examine the cytotoxic effects of Aβ<sub>1-42</sub> fibrils on macrophages, dendritic cells, and microglia. These cells play vitally important roles in development and homeostasis of the central nervous system. We found that Aβ<sub>1-42</sub> fibrils caused calcium release and enhanced levels of reactive oxygen species in macrophages, dendritic cells, and microglia as well as neurons. We also investigated the extent to which the lysozymes of these immune cells could alter the aggregation properties of Aβ<sub>1-42</sub>. Our results showed that lysosomes extracted from macrophages, dendritic cells, and microglia drastically accelerated Aβ<sub>1-42</sub> aggregation as well as altered cytotoxicity of these protein aggregates. These results indicate that impairment of immune cells in the brain can be a critically important aspect of neurodegenerative processes that are taking place upon the onset of AD.

Authors

Institutions

Publication Details

Journal
ACS Chemical Neuroscience
Published
2025-03-08
DOI
https://doi.org/10.1021/acschemneuro.4c00835
Citations
3
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
3.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells

Mikhail Matveyenka, М. В. Шолух, Dmitry Kurouski
3 citations
ACS Chemical Neuroscience
Alzheimer's disease research and treatments
3.49
article

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells

Mikhail Matveyenka, М. В. Шолух, Dmitry Kurouski
article en
3 citations

Abstract

Alzheimer's disease (AD) is a progressive pathology that is linked to abrupt aggregation of amyloid β<sub>1-42</sub> (Aβ<sub>1-42</sub>) peptide in the central nervous system. Aβ<sub>1-42</sub> aggregation yields amyloid oligomers and fibrils, toxic protein aggregates that cause progressive neuronal degeneration in the frontal lobe of the brain. Although neurons remain the focus of AD for decades, a growing body of evidence suggests that the degeneration of immune cells in the brain can be the major cause of AD. However, the extent to which Aβ<sub>1-42</sub> aggregates are toxic to the major classes of immune cells in the brain remains unclear. In the current study, we examine the cytotoxic effects of Aβ<sub>1-42</sub> fibrils on macrophages, dendritic cells, and microglia. These cells play vitally important roles in development and homeostasis of the central nervous system. We found that Aβ<sub>1-42</sub> fibrils caused calcium release and enhanced levels of reactive oxygen species in macrophages, dendritic cells, and microglia as well as neurons. We also investigated the extent to which the lysozymes of these immune cells could alter the aggregation properties of Aβ<sub>1-42</sub>. Our results showed that lysosomes extracted from macrophages, dendritic cells, and microglia drastically accelerated Aβ<sub>1-42</sub> aggregation as well as altered cytotoxicity of these protein aggregates. These results indicate that impairment of immune cells in the brain can be a critically important aspect of neurodegenerative processes that are taking place upon the onset of AD.

ACS Chemical NeuroscienceVol. 16(6)
Mitchell Institute (US), Belarusian State University (BY), Texas A&M University (US)
National Institute of General Medical Sciences
Zero hunger
Openalex Percentile: Top 9%
Alzheimer's disease research and treatments
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.